Continuous glucose monitoring system is used for the continuous measurement of blood glucose. The Continuous glucose monitoring system includes an implantable sensor with wireless transmission capability and a monitor.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Continuous Glucose Monitors under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Continuous Glucose Monitors and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to :
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Continuous Glucose Monitors under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced Biosensors-Ohio LLC
- Advanced Medical Electronics Corp
- Apollon Inc
- Arkal Medical Inc (Inactive)
- Azurite Technologies, Inc. (Inactive)
- Biovotion AG
- CALISTO MEDICAL, INC. (Inactive)
- CGM3 Ltd
- City, University of London
- Columbia University
- ConvaTec Group Plc
- Cyber Medical Ltd (Inactive)
- DexCom Inc
- Echo Therapeutics Inc (Inactive)
- Eclypia
- eLutions Integrated Systems, Inc.
- Flowsion A/S
- Gili Medical Ltd
- Globe Medical Tech Inc (Inactive)
- GlucoLight Corporation (Inactive)
- Glucometrix AG
- GlucoModicum Oy
- Glucosense Diagnostics Ltd (Inactive)
- GlucoTrack Inc
- Glucovation Inc
- GluMetrics Inc
- Glusense Ltd
- GlySens Inc
- Guided Therapeutics Inc
- Hagar Tech
- iGlyko, Inc. (Inactive)
- Innovosens AB
- Invivosense ASA (Inactive)
- I-Sens Inc
- KTH Royal Institute of Technology
- LEMM Technologies, LLC
- Medtronic MiniMed Inc
- Metronom Health Inc
- MicroTech Medical Inc
- mobiLIFE
- Nemaura Medical Inc
- Newton Photonics Inc
- Northwestern University
- PKvitality SAS
- Purdue University
- SD Biosensor Inc
- Senseonics Holdings Inc
- SensiVida Medical Technologies, Inc. (Inactive)
- Socrates Health Solutions, Inc.
- Stony Brook University
- Swansea University
- Tandem Diabetes Care Inc
- Tenax Therapeutics Inc
- Texas A&M University
- Ultradian Diagnostics LLC
- University of California Berkeley
- University of California Irvine
- University of California San Diego
- University of South Carolina
- University of South Florida
- University of Technology Sydney
- University of Texas at Arlington
- Uxn Co Ltd
- VeriTeQ Corporation

